Searchable abstracts of presentations at key conferences in endocrinology

ea0016p38 | Adrenal | ECE2008

Retrospective clinical data on more than 160 pheochromocytoma in three east german endocrine centers

Kopetschke Robert , Kilisli Aylin , Tuschy U , Wallaschofski Henri , Oelkers Wolfgang , Ventz Manfred , Quinkler Marcus

Objective: Pheochromocytoma is a rare disease with an incidence of 2–6 per million, and a prevalence of 0.1–0.6% in patients with hypertension. Pheochromocytoma may occur sporadically or as part of hereditary syndrome. According to the latest studies, among patients with non-syndromic pheochromocytoma, up to 24% of tumors may be inherited. However, genetic testing was not generally performed until recently. There is still a debate which pheochromocytoma patient shoul...

ea0016p333 | Endocrine tumours | ECE2008

Deficits in the clinical management of patients with adrenocortical carcinoma in Germany

Johanssen Sarah , Koschker Ann-Cathrin , Hahner Stefanie , Quinkler Marcus , Saeger Wolfgang , Morcos Michael , Willenberg Holger , Langer Peter , Klose Silke , Reisch Nicole , Beuschlein Felix , Brauckhoff Michael , Fottner Christian , Wortmann Sebastian , Oelkers Wolfgang , Maeder Uwe , Fassnacht Martin , Allolio Bruno

Adrenocortical carcinoma (ACC) is a rare disease with poor prognosis. Accordingly, in many cases, the attending doctors have no previous experience with the disease. The aim of our study was to evaluate the quality of care in a large number of patients with ACC in Germany. Data from 263 adult patients of the German ACC registry were analyzed with regard to the following parameters: time to diagnosis, hormonal assessment, imaging, histopathological documentation, follow-up. The...

ea0016p312 | Endocrine tumours | ECE2008

Prognostic factors in localized adrenocortical carcinoma (ACC) after complete resection

Obracay Jens , Fassnacht Martin , Saeger Wolfgang , Johanssen Sarah , Marcus Quinkler , Linden Tobias , Ann-Kathrin Koschker , Sebastian Wortmann , Morcos Michael , Willenberg Holger , Langer Peter , Behrend Matthias , Klose Silke , Reisch Nicole , Brauckhoff Michael , Petersenn Stephan , Bucsky Peter , Oelkers Wolfgang , Maeder Uwe , Hahner Stefanie , Allolio Bruno

Even after complete resection, patients with ACC have a high risk of relapse, and adjuvant treatment with mitotane is frequently recommended. Although mitotane has significant efficacy in this setting, it is associated with a wide range of side effects. As survival is highly variable, prognostic factors are of great interest to better guide adjuvant therapy after radical resection.We analyzed clinical and histopathological data of patients without distan...